Stock Information

• Spyre: 'Strong Buy' As UC Program Moves Along And Q3 2026 RA Data Looms
  Tue, Mar 17, 2026 2:18 PM
• Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?
  Tue, Mar 17, 2026 12:41 PM
• Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
  Tue, Mar 17, 2026 10:50 AM
• Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
  Tue, Mar 17, 2026 7:27 AM
• Federal Judge Flags Legal Flaws In RFK Jr.'s Vaccine Overhaul
  Tue, Mar 17, 2026 7:19 AM
• Merck To Present New Clinical, Real-World Data Reaffirming Long-Term Effectiveness Of 9-Valent HPV Vaccine, GARDASIL9 And 4-Valent HPV Vaccine, GARDASIL At EUROGIN International Multidisciplinary HPV Congress 2026
  Tue, Mar 17, 2026 6:54 AM
• Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential
  Tue, Mar 17, 2026 5:26 AM
• PJP: Healthcare Dashboard For March
  Tue, Mar 17, 2026 5:12 AM
• Alger Russell Innovation Index Updates for First Quarter 2026
  Mon, Mar 16, 2026 8:05 PM
• U.S. Judge Blocks Trump Administration's Cuts To Number Of Routinely Recommended Vaccines For Children, Blocks Appointments Of 13 Members To Vaccine Panel
  Mon, Mar 16, 2026 3:36 PM

Financial data not available